[1] |
中国免疫学会神经免疫分会. 中国重症肌无力诊断和治疗指南(2020版)[J]. 中国神经免疫学和神经病学杂志, 2021, 28(1):1-12.
|
|
Neuroimmunology Branch of Chinese Society for Immunology. Chinese guidelines for the diagnosis and treatment of myasthenia gravis(2020 version)[J]. Chin J Neuroimmunol Neurol, 2021, 28(1):1-12.
|
[2] |
Chen JS, Tian DC, Zhang C, et al. Incidence,mortality,and economic burden of myasthenia gravis in China:a nationwide population-based study[J]. Lancet Reg Health West Pac, 2020, 5:100063.
|
[3] |
安丽娅, 王旭, 周礼香, 等. 妊娠合并重症肌无力的临床研究进展[J]. 中国计划生育和妇产科, 2021, 13(5):6-8.
|
|
An LY, Wang X, Zhou LX, et al. Progress in clinical research of pregnancy complicated with myasthenia gravis[J]. Chin J Fam Plan & Gynecotokol, 2021, 13(5):6-8.
|
[4] |
Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia gravis:executive summary[J]. Neurology, 2016, 87(4):419-425.
DOI
PMID
|
[5] |
欧昶毅, 冉昊, 邱力, 等. 127例次重症肌无力患者危象前状态相关因素的分析[J]. 中华医学杂志, 2017, 97(37):2884-2889.
|
|
Ou CY, Ran H, Qiu L, et al. Correlation factors of 127 times pre-crisis state in patients with myasthenia gravis[J]. Natl Med J Chin, 2017, 97(37):2884-2889.
|
[6] |
黄玲, 尹世敏, 陆明, 等. 免疫球蛋白对重症肌无力危象前状态的疗效[J]. 北京医学, 2020, 42(5):387-389.
|
|
Huang L, Yin SM, Lu M, et al. Therapeutic effect of globulin on myasthenic pre-crisis state[J]. Beijing Med J, 2020, 42(5):387-389.
|
[7] |
Liu ZG, Lai YR, Yao SY, et al. Clinical outcomes of thymectomy in myasthenia gravis patients with a history of crisis[J]. World J Surg, 2016, 40(11):2681-2687.
PMID
|
[8] |
Braz NFT, Rocha NP, Vieira éLM, et al. Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravis[J]. J Clin Neurosci, 2018, 50:41-44.
DOI
PMID
|
[9] |
刘朝英, 董会民, 乞国艳, 等. 重症肌无力患者自我感受负担及影响因素分析[J]. 中华护理杂志, 2016, 51(4):429-433.
|
|
Liu CY, Dong HM, Qi GY, et al. The level and influencing factors of self-perceived burden in myasthenia gravis patients[J]. Chin J Nurs, 2016, 51(4):429-433.
|
[10] |
中华医学会呼吸病学分会呼吸危重症医学学组, 中国医师协会呼吸医师分会危重症医学工作委员会. 成人经鼻高流量湿化氧疗临床规范应用专家共识[J]. 中华结核和呼吸杂志, 2019, 42(2):83-91.
|
|
Respiratory & Critical Care Medicine Group of Chinese Society of Respiratory Medicine,Chinese Medical Association; Critical Care Medicine Committee of Chinese Medical Doctor Association. Expert consensus of high-flow nasal cannula oxygen therapy on clinical application regularity[J]. Chin J Tuberc Respir Dis, 2019, 42(2):83-91.
|
[11] |
Norkien I, d’Espiney R, Martin-Lazaro JF. Effectiveness of high-flow nasal oxygen therapy in management of acute hypoxemic and hypercapnic respiratory failure[J]. Acta Med Litu, 2019, 26(1):46-50.
DOI
PMID
|
[12] |
黄玲, 尹世敏, 王磊. 重症肌无力危象的防治研究进展[J]. 疑难病杂志, 2019, 18(12):1288-1292.
|
|
Huang L, Yin SM, Wang L. Research progress in the prevention and treatment of myasthenia gravis crisis[J]. Chin J Dif-ficult Complicat Cases, 2019, 18(12):1288-1292.
|